Zur-Rose sets terms on rights issue, will price to market
Zur-Rose, the Swiss retail pharmacy, has set the terms on its Sfr200m new share issuance, to fund the acquisition of Medpex’s e-commerce activities.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: